BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 32196993)

  • 1. Temporal patterns of macrophage- and neutrophil-related markers are associated with clinical outcome in heart failure patients.
    Klimczak-Tomaniak D; Bouwens E; Schuurman AS; Akkerhuis KM; Constantinescu A; Brugts J; Westenbrink BD; van Ramshorst J; Germans T; Pączek L; Umans V; Boersma E; Kardys I
    ESC Heart Fail; 2020 Jun; 7(3):1190-1200. PubMed ID: 32196993
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Temporal Patterns of 14 Blood Biomarker candidates of Cardiac Remodeling in Relation to Prognosis of Patients With Chronic Heart Failure-The Bio- SH i FT Study.
    Bouwens E; Brankovic M; Mouthaan H; Baart S; Rizopoulos D; van Boven N; Caliskan K; Manintveld O; Germans T; van Ramshorst J; Umans V; Akkerhuis KM; Kardys I
    J Am Heart Assoc; 2019 Feb; 8(4):e009555. PubMed ID: 30760105
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Temporal evolution of liver function parameters predicts clinical outcome in chronic heart failure patients (Bio-SHiFT study).
    Klimczak-Tomaniak D; Andrzejczyk K; Abou Kamar S; Baart S; van Boven N; Akkerhuis KM; Constantinescu A; Caliskan K; Simsek S; Germanse T; van Ramshorst J; Brugts J; Kuch M; Umans V; Boersma E; Kardys I
    Cardiol J; 2024; 31(3):409-417. PubMed ID: 38408202
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Sex-specific cardiovascular protein levels and their link with clinical outcome in heart failure.
    de Bakker M; Loncq de Jong M; Petersen T; de Lange I; Akkerhuis KM; Umans VA; Rizopoulos D; Boersma E; Brugts JJ; Kardys I
    ESC Heart Fail; 2024 Feb; 11(1):594-600. PubMed ID: 38009274
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Longitudinally Measured Fibrinolysis Factors are Strong Predictors of Clinical Outcome in Patients with Chronic Heart Failure: The Bio-SHiFT Study.
    van den Berg VJ; Bouwens E; Umans VAWM; de Maat M; Manintveld OC; Caliskan K; Constantinescu AA; Mouthaan H; Cornel JH; Baart S; Akkerhuis KM; Boersma E; Kardys I
    Thromb Haemost; 2019 Dec; 119(12):1947-1955. PubMed ID: 31659734
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Patient-specific evolution of renal function in chronic heart failure patients dynamically predicts clinical outcome in the Bio-SHiFT study.
    Brankovic M; Akkerhuis KM; van Boven N; Anroedh S; Constantinescu A; Caliskan K; Manintveld O; Cornel JH; Baart S; Rizopoulos D; Hillege H; Boersma E; Umans V; Kardys I
    Kidney Int; 2018 Apr; 93(4):952-960. PubMed ID: 29191357
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inflammatory Biomarkers Predict Heart Failure Severity and Prognosis in Patients With Heart Failure With Preserved Ejection Fraction: A Holistic Proteomic Approach.
    Hage C; Michaëlsson E; Linde C; Donal E; Daubert JC; Gan LM; Lund LH
    Circ Cardiovasc Genet; 2017 Feb; 10(1):. PubMed ID: 28100627
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Heart failure subphenotypes based on repeated biomarker measurements are associated with clinical characteristics and adverse events (Bio-SHiFT study).
    de Lange I; Petersen TB; de Bakker M; Akkerhuis KM; Brugts JJ; Caliskan K; Manintveld OC; Constantinescu AA; Germans T; van Ramshorst J; Umans VAWM; Boersma E; Rizopoulos D; Kardys I
    Int J Cardiol; 2022 Oct; 364():77-84. PubMed ID: 35714717
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Circulating Biomarkers of Cell Adhesion Predict Clinical Outcome in Patients with Chronic Heart Failure.
    Bouwens E; van den Berg VJ; Akkerhuis KM; Baart SJ; Caliskan K; Brugts JJ; Mouthaan H; Ramshorst JV; Germans T; Umans VAWM; Boersma E; Kardys I
    J Clin Med; 2020 Jan; 9(1):. PubMed ID: 31936828
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cardiometabolic Biomarkers and Their Temporal Patterns Predict Poor Outcome in Chronic Heart Failure (Bio-SHiFT Study).
    Brankovic M; Akkerhuis KM; Mouthaan H; Brugts JJ; Manintveld OC; van Ramshorst J; Germans T; Umans V; Boersma E; Kardys I
    J Clin Endocrinol Metab; 2018 Nov; 103(11):3954-3964. PubMed ID: 30113647
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Iron deficiency in worsening heart failure is associated with reduced estimated protein intake, fluid retention, inflammation, and antiplatelet use.
    van der Wal HH; Grote Beverborg N; Dickstein K; Anker SD; Lang CC; Ng LL; van Veldhuisen DJ; Voors AA; van der Meer P
    Eur Heart J; 2019 Nov; 40(44):3616-3625. PubMed ID: 31556953
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Serially measured circulating miR-22-3p is a biomarker for adverse clinical outcome in patients with chronic heart failure: The Bio-SHiFT study.
    van Boven N; Akkerhuis KM; Anroedh SS; Rizopoulos D; Pinto Y; Battes LC; Hillege HL; Caliskan KC; Germans T; Manintveld OC; Cornel JH; Constantinescu AA; Boersma E; Umans VA; Kardys I
    Int J Cardiol; 2017 May; 235():124-132. PubMed ID: 28274577
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Combination of ST2 and B-type natriuretic peptide in diabetic patients with acute heart failure: relation with ventricular stiffness and outcome.
    Ruocco G; Evangelista I; Franci B; Lucani B; Martini S; Nuti R; Palazzuoli A
    J Cardiovasc Med (Hagerstown); 2019 Feb; 20(2):81-90. PubMed ID: 30540645
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of functional electrical stimulation on cardiovascular outcomes in patients with chronic heart failure.
    Kadoglou NP; Mandila C; Karavidas A; Farmakis D; Matzaraki V; Varounis C; Arapi S; Perpinia A; Parissis J
    Eur J Prev Cardiol; 2017 May; 24(8):833-839. PubMed ID: 28079427
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Utility of temporal profiles of new cardio-renal and pulmonary candidate biomarkers in chronic heart failure.
    Brankovic M; Martijn Akkerhuis K; Mouthaan H; Constantinescu A; Caliskan K; van Ramshorst J; Germans T; Umans V; Kardys I
    Int J Cardiol; 2019 Feb; 276():157-165. PubMed ID: 30098826
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The prognostic value of highly sensitive cardiac troponin assays for adverse events in men and women with stable heart failure and a preserved vs. reduced ejection fraction.
    Gohar A; Chong JPC; Liew OW; den Ruijter H; de Kleijn DPV; Sim D; Yeo DPS; Ong HY; Jaufeerally F; Leong GKT; Ling LH; Lam CSP; Richards AM
    Eur J Heart Fail; 2017 Dec; 19(12):1638-1647. PubMed ID: 28849609
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Increased visit-to-visit blood pressure variability is associated with worse cardiovascular outcomes in low ejection fraction heart failure patients: Insights from the HEAAL study.
    Rossignol P; Girerd N; Gregory D; Massaro J; Konstam MA; Zannad F
    Int J Cardiol; 2015; 187():183-9. PubMed ID: 25828348
    [TBL] [Abstract][Full Text] [Related]  

  • 18. High-sensitivity C-reactive protein in chronic heart failure: patient characteristics, phenotypes, and mode of death.
    Pellicori P; Zhang J; Cuthbert J; Urbinati A; Shah P; Kazmi S; Clark AL; Cleland JGF
    Cardiovasc Res; 2020 Jan; 116(1):91-100. PubMed ID: 31350553
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Circulating proteins as predictors of incident heart failure in the elderly.
    Stenemo M; Nowak C; Byberg L; Sundström J; Giedraitis V; Lind L; Ingelsson E; Fall T; Ärnlöv J
    Eur J Heart Fail; 2018 Jan; 20(1):55-62. PubMed ID: 28967680
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Myocardial
    Verschure DO; Lutter R; van Eck-Smit BLF; Somsen GA; Verberne HJ
    J Nucl Cardiol; 2018 Jun; 25(3):845-853. PubMed ID: 27858345
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.